Haemostatic markers in patients with abdominal aortic aneurysm and the impact of aneurysm size

Thrombosis Research

Volumn 124, Issue 4, 2009, Pages 423-426

  Wallinder, Jonas ^a   Bergqvist, David ^b   Henriksson, Anders E ^a,b  

^a Sundsvall County Hospital   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Abdominal; Aortic aneurysm; Coagulation; Fibrinolysis

Indexed keywords

D DIMER; FIBRIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; BLOOD CLOTTING; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; FIBRINOLYSIS; HUMAN; MALE; PRIORITY JOURNAL; THROMBIN TIME;

AGED; ANTITHROMBINS; AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMOKING; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

EID: 69249225564     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.01.016     Document Type: Article

References (25)

1. Sakalihasan N., Limet R., and Defawe O.D. Abdominal aortic aneurysm. Lancet 365 (2005) 1577-1589
2. Lederle F.A., Johnson G.R., Wilson S.E., Chute E.P., Hye R.J., Makaroun M.S., et al. The aneurysm detection and management study screening program. Arch Intern Med 160 (2000) 1425-1430
3. The UK Small Aneurysm Trial Participants. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants. Lancet 352 (1998) 1649-1655
4. Lederle F.A., Wilson S.E., Johnson G.R., Reinke D.B., Littooy F.N., Acher C.W., et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 346 (2002) 1437-1444
5. Brady A.R., Fowkes F.G.R., Thompson S.G., and Powell J.T. Aortic aneurysm diameter and risk of cardiovascular mortality. Artrioscler Thromb Vasc Biol 21 (2001) 1203-1207
6. Brady A.R., Thompson S.G., Fowkes F.G.R., Greenhalgh R.M., and Powell J.T. Abdominal Aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 110 (2004) 16-21
7. Powell J.T., and Brady A.R. Detection, management, and prospects for medical treatment of small abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 24 (2004) 241-245
8. Lowe G.D.O., Yarnell J.W.G., Sweetnam P.M., Rumley A., Thomas H.F., and Elwood P.C. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study. Thromb Haemost 79 (1998) 129-133
9. Lowe G.D., Rumley A., Sweetnam P.M., Yarnell J.W.G., and Rumley J. Fibrin D-dimer, markers of coagulation activation and the risk of major ischemic heart disease in the Caerphilly Study. Thromb Haemost 86 (2001) 822-827
10. Morange P.E., Bickel C., Nicaud V., Schnabel R., Rupprecht H.J., Peetz D., et al. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene Study. Arterioscler Thromb Vasc Biol 26 (2006) 2793-2799
11. Enderle M.D., Pfohl M., Kellermann N., Haering H.U., and Hoffmeister H.M. Endothelial function, variables of fibrinolysis and coagulation in smokers and healthy controls. Hemostasis 30 (2000) 149-158
12. Yarnell J.W., Sweetnam P.M., Rumley A., and Lowe G.D. Lifestyle factors and coagulation activation markers: the Caerphilly Study. Blood Coagul Fibrinolysis 12 (2001) 721-728
13. MacCallum P.K. Markers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokers. Proc Am Thorac Soc 2 (2005) 34-43
14. Wannamethee S.G., Lowe G.D.O., Shaper A.G., Rumley A., Lennon L., and Whincup P.H. Association between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 26 (2005) 1765-1773
15. Balduini C.L., Salvini M., Montani N., Noris P., Spedini P., Belletti S., et al. Activation of the hemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. Haematologica 82 (1997) 581-583
16. Yamazumi K., Ojiro M., Okumura H., and Aikou T. An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. Am J Surg 175 (1998) 297-301
17. Holmberg A., Siegbahn A., Westman B., and Bergqvist D. Ischemia and reperfusion during open abdominal aortic aneurysm surgery induce extensive thrombin generation and activity. Eur J Vasc Endovasc Surg 18 (1999) 11-16
18. Wanhainen A., Nilsson T.K., Bergqvist D., Boman K., and Björck M. Elevated tissue plasminogen activator in patients with screening-detected abdominal aortic aneurysm. J Vasc Surg 45 (2007) 1109-1113
19. Grimes D.A., and Schulz K.F. Compared to what? Finding controls for case-control studies. Lancet 365 (2005) 1429-1433
20. Choke E., Cockerill G., Wilson W.R.W., Sayed S., Dawson J., Loftus I., et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 30 (2005) 227-244
21. Tripodi A., and Mannucci P.M. Markers of activated coagulation and their usefulness in the clinical laboratory. Clin Chem 42 (1996) 664-669
22. Jean-Claude J., Newman K.M., Li H., Gregory A.K., and Tilson M.D. Possible key role for plasmin in the pathogenesis of abdominal aortic aneurysms. Surgery 116 (1994) 472-478
23. Touat Z., Ollivier V., Dai J., Huisse M.G., Bezeaud A., Sebbag U., et al. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am J Pathol 168 (2006) 1022-1030
24. van der Putten R.F.M., Glatz J.F.C., and Hermens W.T. Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndromes. Clin Chim Acta 371 (2006) 37-54
25. Bergqvist D., Björck M., and Wanhainen A. Abdominal aortic aneurysm - to screen or not to screen. Eur J Vasc Endovasc Surg 35 (2008) 13-18